RE:RE:RE:RE:RE:RE:RE:RE:RE:ONCY's pelareorep is now Phase 3-ready"Current share price has little/nothing to do with the acquisition price" - This is exemplified by the single agent pre-clinical biotech company Trillium Therapeutics being acquired by Pfizer for US$2.3 Billion at a time when CD47 blockade was just an undefined concept.